Moneycontrol PRO
Loans
Loans
HomeNewsOpinionChart of the Day: Reshoring pharma? Why the US can’t afford to disrupt generic drug supply

Chart of the Day: Reshoring pharma? Why the US can’t afford to disrupt generic drug supply

As US lawmakers push to reshore pharmaceutical production, a crucial question remains—are they focusing on the right cost drivers in healthcare?

April 01, 2025 / 09:17 IST
Chart of the Day: Reshoring pharma? Why the US can’t afford to disrupt generic drug supply

The US spends significantly lower amounts on generic drugs compared to other healthcare services

Unlock This Article

Are you a PRO subscriber? Sign In

What Do You Get

  • Ad free Experience

    Seamless navigation, faster responses.

  • Expert Perspective

    Explore 230+ exclusive editorials every month

  • +

    Uncover Insights from World-Renowned Experts and Journalists

  • Actionable Insights

    40+ weekly investment ideas + 3 to 4 daily technical calls

  • Virtual Events

    Exclusive Live Webinars for Expert Trading & Investment Strategies!

  • Newsletters

    Stay ahead with daily and weekly insights

Unlock exclusive discounts